Corning Life Science Products — Net Sales remained flat by 0.0% to $228.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $228.00M to $228.00M. Over 2 years (FY 2021 to FY 2023), Life Science Products — Net Sales shows a downward trend with a -13.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates growing demand for the company's laboratory products or successful expansion into new research markets, while a decrease may signal market saturation, increased competition, or reduced R&D spending by customers.
This metric represents the total revenue generated from the sale of goods and services within the Life Science Products...
Comparable to revenue metrics for life science tools and laboratory supply segments at diversified industrial or healthcare technology peers.
glw_segment_life_science_products_net_sales| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $312.00M | $304.00M | $315.00M | $307.00M | $304.00M | $297.00M | $279.00M | $247.00M | $222.00M | $221.00M | $232.00M | $225.00M | $237.00M | $235.00M | $228.00M | $228.00M |
| QoQ Change | — | -2.6% | +3.6% | -2.5% | -1.0% | -2.3% | -6.1% | -11.5% | -10.1% | -0.5% | +5.0% | -3.0% | +5.3% | -0.8% | -3.0% | +0.0% |
| YoY Change | — | — | — | — | -2.6% | -2.3% | -11.4% | -19.5% | -27.0% | -25.6% | -16.8% | -8.9% | +6.8% | +6.3% | +1.3% | +0.0% |